Re-Vana in Northern Ireland’s Top 10 Most Innovative Technology Companies
Re-Vana ranks 10th in BusinessCloud’s Northern Ireland Tech 50 ranking for 2020.
Visionary Partner & KOL, Ehsan Sadri, Weighs in on Tarsus Pharmaceuticals in CRST Article
Tarsus TP-03: Potential Game-Changer for Demodex Blepharitis
Tarsus Pharmaceuticals Announces Appointment of New COO and CFO
Sesha Neervannan, PhD, to assume position of Chief Operating Officer; Leo Greenstein to assume position of Chief Financial Officer
Optometric Management Interviews TearClear CEO Robert Dempsey
Robert J. Dempsey recently joined TearClear, an emerging global ophthalmic pharmaceutical company with a focus on eye drops that are preserved safely prior to administering dosing, as Chief Executive Officer. Prior to this role, Mr. Dempsey held positions at Shire (Takeda, now Novartis), Bausch + Lomb, Allergan and Inspire Pharmaceuticals. What follows is a Q&A with Mr. Dempsey, where he reveals, among other things, his love of American history.